PRELLIS EXTERNALIZED HUMAN IMMUNE SYSTEM Trademark

Trademark Overview

On Thursday, May 21, 2020, a trademark application was filed for PRELLIS EXTERNALIZED HUMAN IMMUNE SYSTEM with the United States Patent and Trademark Office. The USPTO has given the PRELLIS EXTERNALIZED HUMAN IMMUNE SYSTEM trademark a serial number of 88927381. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, November 20, 2024. This trademark is owned by Prellis Biologics, Inc.. The PRELLIS EXTERNALIZED HUMAN IMMUNE SYSTEM trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Laboratory apparatus and instruments for producing antibodies to prevent and treat viral related diseases and disorders, namely, pipettes, cell culture flasks, cell culture dishes, and tissue culture on a chip with media reservoirs; none of the foregoing for medical use

Scientific and pharmaceutical research, development, engineering and antibody testing services in the fields of viral related diseases and disorders, immunopharmaceuticals, and antibodies; Scientific and pharmaceutical research, development, engineering and antibody testing of prophylactic treatments of viral related diseases and disorders; all of the foregoing being for scientific research purposes only and not for medical diagnostic or treatment purposes

General Information

Serial Number88927381
Word MarkPRELLIS EXTERNALIZED HUMAN IMMUNE SYSTEM
Filing DateThursday, May 21, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, November 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Goods and ServicesLaboratory apparatus and instruments for producing antibodies to prevent and treat viral related diseases and disorders, namely, pipettes, cell culture flasks, cell culture dishes, and tissue culture on a chip with media reservoirs; none of the foregoing for medical use
NOT AVAILABLE"HUMAN IMMUNE SYSTEM"
Goods and ServicesScientific and pharmaceutical research, development, engineering and antibody testing services in the fields of viral related diseases and disorders, immunopharmaceuticals, and antibodies; Scientific and pharmaceutical research, development, engineering and antibody testing of prophylactic treatments of viral related diseases and disorders; all of the foregoing being for scientific research purposes only and not for medical diagnostic or treatment purposes

Classification Information

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateSaturday, June 6, 2020
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrellis Biologics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NamePrellis Biologics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Monday, May 25, 2020NEW APPLICATION ENTERED
Saturday, June 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 21, 2020ASSIGNED TO EXAMINER
Saturday, August 29, 2020NON-FINAL ACTION WRITTEN
Saturday, August 29, 2020NON-FINAL ACTION E-MAILED
Saturday, August 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 23, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 23, 2021NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 20, 2021SUSPENSION LETTER WRITTEN
Wednesday, October 20, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, October 20, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 20, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, July 20, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 12, 2022ASSIGNED TO LIE
Monday, August 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 24, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 24, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 24, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 22, 2023SOU EXTENSION 1 FILED
Tuesday, May 23, 2023PETITION TO REVIVE-GRANTED
Tuesday, May 23, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 23, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, May 24, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, July 6, 2023SOU EXTENSION 1 GRANTED
Friday, July 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 2 FILED
Thursday, November 16, 2023SOU EXTENSION 2 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 20, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 20, 2024SOU EXTENSION 3 GRANTED
Monday, May 20, 2024SOU EXTENSION 3 FILED
Tuesday, May 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024SOU EXTENSION 4 FILED
Wednesday, November 20, 2024SOU EXTENSION 4 GRANTED
Monday, July 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

system immune human externalized prellis diseases disorders research culture viral related scientific cell pharmaceutical engineering